The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Riedell, Peter
Item TypeName
Concept Carcinoma
Concept Palliative Care
Concept Patient Care Team
Concept Preoperative Care
Concept Thrombocytopenia
Concept Thiotepa
Concept Time Factors
Concept Tomography, X-Ray Computed
Concept Tissue Donors
Concept Troponin
Concept Practice Guidelines as Topic
Concept Hematopoietic Stem Cell Transplantation
Concept Health Care Rationing
Concept Stem Cell Transplantation
Concept Treatment Outcome
Concept Transplantation Conditioning
Concept Venous Thromboembolism
Concept Triazoles
Concept Tumor Lysis Syndrome
Concept Standard of Care
Concept Clinical Trials as Topic
Concept Receptors, Antigen, T-Cell
Concept T-Lymphocytes
Concept Translocation, Genetic
Concept Transplantation, Autologous
Concept Transplantation, Homologous
Concept Maximum Tolerated Dose
Academic Article Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma.
Academic Article Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.
Academic Article Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone.
Academic Article A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia.
Academic Article Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
Academic Article Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy.
Academic Article Short- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy.
Academic Article Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL?
Academic Article Post-autologous transplant maintenance therapies in lymphoma: current state and future directions.
Academic Article Double hit and double expressors in lymphoma: Definition and treatment.
Academic Article Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults.
Academic Article Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma.
Academic Article Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia.
Academic Article Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival.
Academic Article Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation.
Academic Article Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas.
Academic Article Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
Academic Article Advances in CAR T-Cell Therapy for Aggressive B-NHL.
Academic Article Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients.
Academic Article Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses.
Academic Article Navigating Dilemmas in Treatment Choice: Our Approach to Supplemental Apheresis Prior to Enrollment in Early- Phase Cellular Therapy Clinical Trials.
Academic Article Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
Academic Article Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant.
Academic Article Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.
Academic Article Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Academic Article Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL.
Academic Article Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
Academic Article Antigen-Multimers: Specific, Sensitive, Precise, and Multifunctional High-Avidity CAR-Staining Reagents.
Academic Article Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.
Academic Article Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial.
Academic Article A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.
Academic Article Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Academic Article Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas.
Academic Article Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy.
Academic Article Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome.
Academic Article Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
Academic Article Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results.
Academic Article A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.
Concept Cell- and Tissue-Based Therapy
Academic Article Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.
Academic Article Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Academic Article Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma.
Academic Article Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.
Academic Article Infectious complications of car T-cell therapy: A longitudinal risk model.
Academic Article Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma.
Academic Article Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
Academic Article If They RECUR, You Should Refer: A Community Oncologist Patient ID Roundtable Summary.
Search Criteria
  • CAR
  • T
  • cell therapy